The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lacosamide Krka 200 mg film-coated tablets

200 milligram(s) Film-coated tablet

KRKA, d.d., Novo mestoPA1347/099/004

Main Information

Trade NameLacosamide Krka 200 mg film-coated tablets
Active SubstancesLacosamide
Strength200 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/099/004

Group Information

ATC CodeN03AX18 lacosamide

Status

Authorised/WithdrawnAuthorised
Licence Issued25/09/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back